| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/07/2006 | CN1781916A Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/06/2006 | US7057014 dissolving nonapeptides/decapeptides (luteinizing hormone-releasing hormone antagonists) in solvent mixture comprising water and alcohol (methanol), stirring with methyl acetate, preciptating, washing, then drying |
| 06/06/2006 | US7056883 Therapeutic agent for soft tissue sarcoma |
| 06/06/2006 | US7056735 Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator) |
| 06/06/2006 | US7056729 Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain |
| 06/06/2006 | US7056666 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056505 Antibody for use in the diagnosis, prevention and treatment of infections, autoimmune disorders, arthritis, graft rejection and graft-versus-host disease |
| 06/01/2006 | WO2006057303A1 Glycopeptide antibiotic monomer derivatives |
| 06/01/2006 | WO2006057288A1 Glycopeptide antibiotic dimer derivatives |
| 06/01/2006 | WO2006057027A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 06/01/2006 | WO2006056009A1 Peptides having adhesive properties for use in solid phase assay and chemical polymer synthesis regimes. |
| 06/01/2006 | WO2006047049A3 Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof |
| 06/01/2006 | WO2006039163A3 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 06/01/2006 | WO2005121178A3 Immunoaffinity chromatography polyol-responsive monoclonal antibodies |
| 06/01/2006 | US20060115451 Modified cytokines for use in cancer therapy |
| 06/01/2006 | CA2589460A1 New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 06/01/2006 | CA2588285A1 Glycopeptide antibiotic monomer derivatives |
| 06/01/2006 | CA2587889A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 06/01/2006 | CA2587775A1 Plasmin-inhibitory therapies |
| 05/31/2006 | EP1661910A1 Peptides capable of binding to titanium, silver and silicone |
| 05/31/2006 | EP1661908A1 Reagent for amplifying amyloid fibrosis of amyloid beta-protein |
| 05/31/2006 | EP1661566A2 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 05/31/2006 | EP1660659A2 Gdnf-related neuropeptides |
| 05/31/2006 | EP1660522A2 Pharmaceutical composition with increased bioavailability suitable for the administration of oral retroviral protease inhibitors. process for preparing a concentrate pharmaceutical composition comprising a retroviral protease inhibitor |
| 05/31/2006 | EP1660521A2 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP1660112A2 Orally administered small peptides synergize statin activity |
| 05/31/2006 | EP1660017A2 Amino acid prodrugs |
| 05/31/2006 | EP1604032A4 Method for detecting prognosis of cancer |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1272223B1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 05/31/2006 | CN1781021A N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 05/31/2006 | CN1257915C Adherence peptide specific to tissue of liver cancer obtained through sieve method in rivo and usage |
| 05/30/2006 | US7053178 biotinylation; for inhibiting activity of anti-beta-2-glycoprotein 1 monoclonal antibodies in vitro |
| 05/30/2006 | US7053047 Cyclic pentapeptides and their preparation |
| 05/26/2006 | WO2006054829A1 Ubidine, peptide isolated from aspergillus nidulans and antibiotics containing the same |
| 05/26/2006 | WO2006054801A1 New cyclic peptide compound |
| 05/26/2006 | WO2006054641A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | WO2006054102A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | WO2005118634A3 Helical peptidomimetics with enhanced activity against beta-amyloid production |
| 05/26/2006 | WO2005115174A3 Alpha-msh-antagonist didpeptide conjugates |
| 05/26/2006 | CA2587398A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | CA2587224A1 Microcin b17 analogs and methods for their preparation and use |
| 05/25/2006 | WO2006032457A9 Peptide cyclisation |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111301 Methods for preventing and treating alzheimer's disease |
| 05/25/2006 | US20060111299 Compositions and methods for treating atherosclerosis |
| 05/25/2006 | US20060111281 Melanocortin receptor-specific |
| 05/25/2006 | US20060111280 Novel substance fki-1033 and process for producing the same |
| 05/25/2006 | US20060111277 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 05/25/2006 | US20060110777 Structured peptide scaffold for displaying turn libraries on phage |
| 05/24/2006 | EP1658036A2 Estrogen receptor modulators and uses thereof |
| 05/24/2006 | EP1509390A4 Carbon nanotube binding peptides |
| 05/24/2006 | EP1466614A4 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 05/24/2006 | EP1383480A4 Lipid-comprising drug delivery complexes and methods for their production |
| 05/24/2006 | EP1373305B1 Process for producing trunkamide a compounds |
| 05/24/2006 | EP1257568B1 Novel echinocandin derivatives, preparation method and use thereof as fungicides |
| 05/24/2006 | EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 05/24/2006 | CN1777439A Somatostatin vectors |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/23/2006 | US7049413 MAGE-A3 peptides presented by HLA class II molecules |
| 05/23/2006 | US7049398 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 05/23/2006 | US7049397 Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons |
| 05/23/2006 | US7049396 Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes |
| 05/23/2006 | US7049395 For therapy of inflammatory disorders |
| 05/23/2006 | US7049295 Compounds and use thereof to modify transport across cell membranes |
| 05/23/2006 | US7049293 Peptide and osteogenetic accelerator |
| 05/23/2006 | US7049292 Administering a peptide having a sequence of QPLALEGSLQK in combination with another polypeptide to treat insulin dependent diabetes mellitus (IDDM or Type 1 diabetes) |
| 05/23/2006 | US7049289 Labelled glutamine and lysine analogues |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049061 use of R-2,4-diaminobutyric acid as a replacement for gamma-aminobutyric acid to make the hairpin loop; bind to the minor groove of a promoter region of a DNA sequence; tighter binding of the polyamides to the minor groove of DNA and also provides an amine function for derivatizing |
| 05/23/2006 | US7048947 Sustained-release preparation |
| 05/18/2006 | WO2006053015A2 Composition and method for increasing apoptosis in cancer cells |
| 05/18/2006 | WO2006052775A2 Peptide anti - tumor agent |
| 05/18/2006 | WO2006052637A1 Retrocyclins: antiviral and antimicrobial peptides |
| 05/18/2006 | WO2006052499A1 Capreomycin derivatives and their use as antibacterials |
| 05/18/2006 | WO2006050930A2 Conjugates with enhanced cell uptake activity |
| 05/18/2006 | WO2006050611A1 Antimicrobial peptides |
| 05/18/2006 | WO2005123760A3 Treating cancer |
| 05/18/2006 | WO2005108432A3 Cd80 (b7-1) binding peptides and uses thereof |
| 05/18/2006 | WO2005103072A8 Convergent synthesis for kahalalide compounds |
| 05/18/2006 | WO2005077044A3 Rational design and engineering of proteins and peptides for immunomodulation |
| 05/18/2006 | WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | US20060106199 Streptavidin-binding peptide |
| 05/18/2006 | US20060106198 Peptides corresponding to active site of N-terminal extension of subunits composing specific adhesive organelles of virulence of pathogenic bacteria; inhibit surface expression of adhesive organelles and thus prevent development of infections; decrease therapeutic dose; reduce side effects |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060105959 Organic compounds with biological action as thrombin inhibitors and use thereof |
| 05/18/2006 | US20060105956 Phenotypic reversion of pancreatic carcinoma cells |
| 05/18/2006 | US20060105949 Pharmaceutical preparations and methods for inhibiting tumors |
| 05/18/2006 | US20060105947 Novel chimeric analgesic peptides |
| 05/18/2006 | US20060105943 Administering cyclic peptides; arthritis, inflammations, osteoporosis, retinopathies, contraception |
| 05/18/2006 | US20060105942 Inhibition of cell division based use of analogs of neuropeptide y |
| 05/18/2006 | US20060105336 autologous T cell vaccines; multiple sclerosis |
| 05/18/2006 | US20060104992 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating HIV |
| 05/18/2006 | DE3830494B4 Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe Water-soluble mono esters as solubilizers for pharmacologically active substances and pharmaceutical excipients |
| 05/18/2006 | DE102004055541A1 Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut Cosmetic and dermatological compositions for the treatment of mature skin |
| 05/18/2006 | CA2629751A1 Antimicrobial peptides |
| 05/18/2006 | CA2586915A1 Molecules which promote hematopoiesis |